Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

HEMISPHERX BIOPHARMA, INC

Delayed Nyse  -  08:00 2019-06-14 pm EDT
5.080 USD   -5.05%
09/28Jonathan Thomas Jorgl Mails a Letter to Shareholders of AIM ImmunoTech
CI
09/28Jonathan Thomas Solicits Proxies from Shareholder of AIM ImmunoTech Inc
CI
09/26AIM ImmunoTech Solicits Proxies from Shareholders
CI
SummaryChartsNewsRatingsCalendarCompanyFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about HEMISPHERX BIOPHARMA, INC
09/28Jonathan Thomas Jorgl Mails a Letter to Shareholders of AIM ImmunoTech
CI
09/28Jonathan Thomas Solicits Proxies from Shareholder of AIM ImmunoTech Inc
CI
09/26AIM ImmunoTech Solicits Proxies from Shareholders
CI
09/23Jonathan Thomas Solicits Proxies from the Shareholders
CI
09/21AIM ImmunoTech Solicits Proxies from Shareholders
CI
09/21AIM ImmunoTech to Present at the Virtual Investor Long COVID Event
GL
09/21AIM ImmunoTech to Present at the Virtual Investor Long COVID Event
AQ
09/20AIM ImmunoTech Board Files Definitive Proxy Statement and Sends Letter to Shareholders
CI
09/19AIM ImmunoTech Board Files Definitive Proxy Statement and Sends Letter to Shareholders
BU
09/19AIM ImmunoTech Solicits Proxies from the Shareholders
CI
09/15Aim Immunotech : Proactive - 9/14/22 - Interview with AIM CEO Thomas K. Equels
PU
09/15Jonathan Thomas Solicits Proxies from Shareholder of AIM ImmunoTech Inc
CI
09/07AIM ImmunoTech to Present at the H.C. Wainwright 24th Annual Global Investment Conferen..
GL
09/07AIM ImmunoTech to Present at the H.C. Wainwright 24th Annual Global Investment Conferen..
AQ
09/06AIM ImmunoTech Selected to Present at the 2nd Annual Marie Sklodowska-Curie Symposium o..
GL
More most relevant news
All news about HEMISPHERX BIOPHARMA, INC
09/28Jonathan Thomas Jorgl Mails a Letter to Shareholders of AIM ImmunoTech
CI
09/28Jonathan Thomas Solicits Proxies from Shareholder of AIM ImmunoTech Inc
CI
09/26AIM ImmunoTech Solicits Proxies from Shareholders
CI
09/23Jonathan Thomas Solicits Proxies from the Shareholders
CI
09/21AIM ImmunoTech Solicits Proxies from Shareholders
CI
09/21AIM ImmunoTech to Present at the Virtual Investor Long COVID Event
GL
09/21AIM ImmunoTech to Present at the Virtual Investor Long COVID Event
AQ
09/20AIM ImmunoTech Board Files Definitive Proxy Statement and Sends Letter to Shareholders
CI
09/19AIM ImmunoTech Board Files Definitive Proxy Statement and Sends Letter to Shareholders
BU
09/19AIM ImmunoTech Solicits Proxies from the Shareholders
CI
More news
News in other languages on HEMISPHERX BIOPHARMA, INC
09/20Le conseil d'administration d'AIM ImmunoTech dépose une déclaration de procuration défi..
08/30AIM ImmunoTech déclare que le recrutement est en cours dans le cadre de l'étude de phas..
08/30AIM ImmunoTech Inc. et le collaborateur de l'étude, Roswell Park, commencent le recrute..
08/30AIM ImmunoTech Inc. et le Roswell Park Comprehensive Cancer Center commencent le recrut..
08/18AIM ImmunoTech annonce le lancement d'un essai de phase 2 sur Ampligen pour le traiteme..
08/18AIM ImmunoTech Inc. annonce le début de l'étude de phase 2 d'Ampligen(R) pour le traite..
08/16Jonathan Jorgl réitère son intention de procéder aux nominations et à la sollicitation ..
08/15AIM ImmunoTech fait le point sur le litige concernant Jonathan Jorgl
08/15AIM ImmunoTech Inc. annonce ses résultats pour le deuxième trimestre et les six mois te..
07/28AIM ImmunoTech rapporte des données positives d'une étude pilote du programme d'accès é..
More news
Analyst Recommendations on HEMISPHERX BIOPHARMA, INC
02/02Maxim Group Adjusts AIM ImmunoTech Price Target to $3 From $5, Maintains Buy Rating
MT
More recommendations
Press releases
09/21AIM ImmunoTech to Present at the Virtual Investor Long COVID Event
GL
09/21AIM ImmunoTech to Present at the Virtual Investor Long COVID Event
AQ
09/19AIM ImmunoTech Board Files Definitive Proxy Statement and Sends Letter to Shareholders
BU
09/15Aim Immunotech : Proactive - 9/14/22 - Interview with AIM CEO Thomas K. Equels
PU
09/09Aim Immunotech Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-..
AQ
More press releases
Upcoming event on HEMISPHERX BIOPHARMA, INC